Michel Vounatsos's Net Worth

$24 Million

Estimate Recalculated Nov 8, 2024 09:31PM EST

Who is Michel Vounatsos

Michel Vounatsos has an estimated net worth of $24 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., REVVITY, INC., and Zai Lab Ltd.

SEC CIK

Michel Vounatsos's CIK is 0001672709

Past Insider Trading and Trends

2020 was Michel Vounatsos's most active year for acquiring shares with 10 total transactions. Michel Vounatsos's most active month to acquire stocks was the month of January. 2021 was Michel Vounatsos's most active year for disposing of shares, totalling 10 transactions. Michel Vounatsos's most active month to dispose stocks was the month of January. 2019 saw Michel Vounatsos paying a total of $1,007,169.48 for 55,569 shares, this is the most they've acquired in one year. In 2021 Michel Vounatsos cashed out on 51,665 shares for a total of $4,023,928.19, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOGEN INC.

Chief Executive Officer
Updated Feb 23, 2022
Form 4
-10.68%
-11.65K
$209.79
-$576.08K
Feb 23, 2022
97.47K
Options
Feb 18
Form 4
-24.61%
-24.93K
$214.59
-$1.84M
Feb 15, 2022
76.38K
Options
Feb 12
Form 4
28.41K
Feb 14, 2022
92.07K
Grant
Feb 10
Form 4
19.96%
10.59K
Jan 21, 2022
63.67K
Grant
Jan 19
Form 4
45.31K
Feb 22, 2021
45.31K
Grant
Feb 18
Form 4
-28.08%
-35.38K
$278.03
-$4.02M
Feb 17, 2021
90.62K
Options
Feb 12
Form 4
46.95%
16.34K
Jan 29, 2021
51.15K
Grant
Jan 27
Form 4
9.78%
3.10K
$241.31
$748.05K
Dec 01, 2020
34.81K
Purchase
Nov 30
Form 4
-15.51%
-5.81K
$333.00
-$715.95K
Feb 19, 2020
31.63K
Options
Feb 15
Form 4
24.10%
20.15K
$331.76
-$1.62M
Feb 14, 2020
103.77K
Options
Feb 12
Form 4
-10.02%
-2.43K
$230.52
-$151.68K
May 06, 2019
21.83K
Options
May 02
Form 4
26.12%
4.35K
$231.48
$1.01M
May 02, 2019
21.01K
Purchase
May 01
Form 4
-18.17%
-5.57K
$332.87
-$778.92K
Feb 20, 2019
25.08K
Options
Feb 15
Form 4
65.10%
29.74K
$319.43
-$837.55K
Feb 14, 2019
75.43K
Options
Feb 12
Form 4
-15.45%
-2.31K
$274.13
-$205.60K
May 04, 2018
12.62K
Options
May 02
Form 4
-16.53%
-5.02K
$299.38
-$561.94K
Feb 20, 2018
25.36K
Options
Feb 15
Form 4
36.32K
Feb 14, 2018
36.32K
Grant
Feb 12
Form 4
19.03%
780.00
$320.55
$250.03K
Jan 02, 2018
4.88K
Purchase
ScheduledDec 29
Form 4
-16.36%
-2.07K
$271.34
-$153.04K
May 04, 2017
10.60K
Options
May 02
Form 4
91.91%
1.40K
$271.35
$380.43K
May 02, 2017
2.93K
Purchase
ScheduledMay 01
Form 4
1,320.70%
1.33K
$285.39
$380.42K
Mar 01, 2017
1.43K
Purchase
ScheduledFeb 27
Form 4
25.50K
Feb 17, 2017
25.50K
Grant
Feb 15
Form 4
9.52K
May 04, 2016
9.52K
Grant
May 02
Form 3
Apr 22, 2016
Showing 24 results

REVVITY, INC.

Investor
Updated May 02, 2024
Form 4
30.96%
2.19K
May 02, 2024
9.29K
Grant
May 01
Form 4
32.47%
1.74K
May 17, 2023
7.09K
Grant
May 15
Form 4
33.87%
1.35K
May 09, 2022
5.35K
Grant
May 06
Form 4
48.90%
1.31K
May 10, 2021
4.00K
Grant
May 07
Form 4
513.01%
2.25K
$92.20
$22.50K
May 12, 2020
2.69K
Grant
May 08
Form 4
438.00
Mar 17, 2020
438.00
Grant
Mar 16
Form 3
Mar 02, 2020
Showing 7 results

Zai Lab Ltd

Investor
Updated Jun 20, 2024
Form 4
115.93%
21.25K
Jun 20, 2024
39.59K
Grant
Jun 18
Form 4
18.33K
Mar 07, 2023
18.33K
Grant
Mar 03
Form 3
Jan 13, 2023
Showing 3 results